The surgical site infection market is growing on account of a rise in the volume of surgeries and resulting infections, growing geriatric population, and advancements in technology. The domain size, which was $4.0 billion in 2017, is expected to grow to $5.9 billion by 2023 at a CAGR of 6.4% during 2018–2023 (forecast period). By definition, the market includes all the equipment and procedures used to prevent or treat surgical infections. On the basis of phase, the market can be divided into preoperative, intraoperative, and postoperative.

Request to get the sample pages of the report:

Among these, antibiotic prophylaxis products generated $761.1 million in 2017 for the market on their own, as these are the most common method to prevent infections. Besides these, antiseptics and disinfectants are also widely used during and after surgeries, which is why this category is expected to grow the fastest in the surgical site infection market during the forecast period at a CAGR of 7.4%. Because of the presence of biocides, antiseptics and disinfectants are being increasingly used before surgeries to minimize the chances of SSIs.

Across the globe, the domain is advancing due to the growing volume of surgeries and rising incidents of SSIs. According to the World Bank, 30,537 surgeries were done per 100,000 people in the U.S. in 2012, while the number for Australia stood at 28,907 per 100,000 people. Now, a lot of surgeries, even though all preventive measures are taken, result in infections. As per the European Centre for Disease Prevention and Control, between 2013 and 2014, of the 967,191 surgeries performed in Europe, 18,364 resulted in infections. Thus, with the growing number of surgeries in the future, the incidents of infection will also increase, taking the SSI market forward.

Now, one of the primary reasons the volume of surgeries is growing is the increase in geriatric population. As the elderly are more prone to diseases requiring surgical intervention, a rise in their population will automatically propel the number of surgeries performed. Further, aged people are also more susceptible to infections on account of their low immunity, which is why such people would be another primary growth driver of the surgical site infection market during the forecast period.

Globally, North America contributed the highest revenue share (38.4%) to the domain in 2017, owing to a growing awareness about SSIs, presence of a large number of SSI product manufacturers, and developed healthcare infrastructure. While the continent will still lead the SSI market during the forecast period, Asia-Pacific will witness the fastest growth, at a 7.7% CAGR. This can be attributed to the increase in geriatric population, improvements in healthcare infrastructure, rising incidents of such infections, and penetration of advanced products for SSI prevention and management.

Therefore, it is clear that the growth in geriatric population will result in an increase in the number of surgeries, which will further the market for SSI across the world.

Know More: